Placebo for MK-7240, tulisokibart
MK-7240-013
Phase 2 small_molecule active
Quick answer
Placebo for MK-7240, tulisokibart for Radiographic axial spondyloarthritis (as known as ankylosing spondylitis) is a Phase 2 program (small_molecule) at Merck Sharp and Dohme with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Merck Sharp and Dohme
- Indication
- Radiographic axial spondyloarthritis (as known as ankylosing spondylitis)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active